Investing
AstraZeneca shares fall 3.6% to 7-1/2 week low
© Reuters. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
LONDON (Reuters) – Shares in London-listed drugmaker AstraZeneca (NASDAQ:) declined as much as 3.6% on Monday, falling to their lowest since July 19.
Traders attributed the move to a report in the Mail on Sunday newspaper saying the drugmaker’sChief Executive Pascal Soriot had said privately to friends and advisers that he may leave the company as soon as next year.
Reuters could not independently verify the information.
AstraZeneca declined to comment on the report.
Read the full article here
-
Side Hustles3 days ago
Why the Best CEOs Think Like Anthropologists
-
Side Hustles6 days ago
LA Rental Prices Skyrocketing Despite Price Gouging Laws
-
Side Hustles6 days ago
How to Craft Marketing Campaigns That Reach Multiple Generations
-
Make Money4 days ago
Earn More in 2025: Top 10 High-Yield Savings Accounts Revealed
-
Side Hustles4 days ago
What to Do If TikTok is Banned — How to Protect Your Brand
-
Passive Income4 days ago
How Pets Can Promote Better Health and Well-Being in the Workplace
-
Make Money5 days ago
Build Your Future: 5 Simple Steps to Financial Stability
-
Side Hustles4 days ago
10 Roles That Are Surprisingly Well-Suited for Outsourcing